ArticleJournal of human hypertension2006
Dual ACE/NEP inhibitors - more than playing the ACE card.
Article in Journal of human hypertension, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- A Novel PTPN2 Isoform Differentially Regulates Immune Response.European journal of immunology · 2026Article
- Discovery of Novel Multi-target Inhibitor of angiotensin type 1 receptor and neprilysin inhibitors from Traditional Chinese Medicine.Scientific reports · 2019Article
- Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.Pharmacological reviews · 2019Review
- Large-scale chemical similarity networks for target profiling of compounds identified in cell-based chemical screens.PLoS computational biology · 2015Article
- Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network.PloS one · 2015Article
- An ab initio quantum mechanical drug designing procedure: application to the design of balanced dual ACE/NEP inhibitors.Journal of molecular modeling · 2009Article
- Extracellular proteases as targets for drug development.Current protein & peptide science · 2009Review
- Re-sensitization of neuropeptide receptors: should we stop the recycling?British journal of pharmacology · 2009Article
- The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?British journal of pharmacology · 2008Review
- Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.British journal of pharmacology · 2008Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
16543904What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.